GSE239844 crizotinib 1 v 10 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844_crizotinib_1_v_10_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844_crizotinib_1_v_10_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844_crizotinib_1_v_10_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844_crizotinib_1_v_10_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H2B clustered histone 8

Gene

H3 clustered histone 7

Gene

MSL complex subunit 3B

Gene

tripartite motif containing 16 like (pseudogene)

Gene

cytoskeleton regulator RNA

Gene

MIR1915 host gene

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

zinc finger protein 883

Gene

Myb/SANT DNA binding domain containing 7

Gene

long intergenic non-protein coding RNA 973

  • Gene

    H2B clustered histone 8


  • Gene

    H3 clustered histone 7


  • Gene

    MSL complex subunit 3B


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    cytoskeleton regulator RNA



  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    zinc finger protein 883


  • Gene

    Myb/SANT DNA binding domain containing 7


  • Gene

    long intergenic non-protein coding RNA 973

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.